Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNAO1 | P09471 | 10/20 | 0.40 |
| ▸ | GNAI3 | P08754 | 9/20 | 0.40 |
| ▸ | GNAI1 | P63096 | 9/20 | 0.40 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.31 |
| ▸ | FDPS | P14324 | 1/20 | 0.31 |
| ▸ | CNR1 | P21554 | 1/20 | 0.31 |
| ▸ | DPP4 | P27487 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26621076 | 1.00 | GNAO1 (0.40) | GNAO1GNAI3GNAI1SPHK1HTT | |
| SCHEMBL26603959 | 1.00 | GNAO1 (0.40) | GNAO1GNAI3GNAI1SPHK1HTT | |
| SCHEMBL26603963 | 0.90 | GNAO1 (0.38) | GNAO1GNAI3GNAI1SPHK1CYP1A2 | |
| SCHEMBL26641123 | 0.90 | GNAO1 (0.38) | GNAO1GNAI3GNAI1SPHK1CYP1A2 | |
| SCHEMBL26635458 | 0.88 | GNAO1 (0.37) | GNAO1GNAI3GNAI1SPHK1CYP1A2 | |
| SCHEMBL26661133 | 0.87 | GNAO1 (0.36) | GNAO1GNAI3GNAI1SPHK1CYP1A2 | |
| SCHEMBL26655861 | 0.83 | GNAI3 (0.35) | GNAO1GNAI3GNAI1SPHK1SMPD1 | |
| SCHEMBL26630625 | 0.83 | GNAI3 (0.35) | GNAO1GNAI3GNAI1SPHK1SMPD1 | |
| SCHEMBL26603919 | 0.83 | GNAI3 (0.35) | GNAO1GNAI3GNAI1SPHK1SMPD1 | |
| SCHEMBL26604175 | 0.80 | GNAO1 (0.35) | GNAO1GNAI3GNAI1SPHK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11795192-B2 | Antimicrobial compounds, compositions, and uses thereof | Lakewood Amedex, Inc. (US) | 2023-10-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11795192-B2 | Antimicrobial compounds, compositions, and uses thereof | CAT, MPO, NISCH | GNAO1 4664/4885GNAI3 3835/4885GNAI1 3923/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.